The role of synaptic proteins in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 924, Issue , 2000, Pages 68-75

  Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloidogenesis; Neurodegeneration; Protein aggregation; Protein misfolding; Synapses

Indexed keywords

BRAIN PROTEIN;

ALZHEIMER DISEASE; CELL DEATH; COMPLEX FORMATION; CONFERENCE PAPER; HUMAN; HYDROPHOBICITY; NERVE DEGENERATION; OXIDATIVE STRESS; PREDICTION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; SYNAPTIC TRANSMISSION;

EID: 0034509452     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05562.x     Document Type: Conference Paper

References (38)

1. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions
2. Synaptic and neuritic alterations during the progression of Alzheimer's disease
3. Role of the beta-amyloid protein in Alzheimer's disease
4. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
5. Molecular mechanisms of synaptic disconnection in Alzheimer's disease
6. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
7. Molecular cloning of a novel component of amyloid in Alzheimer's disease
8. Identification of two distinct synucleins from human brain
9. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation
10. The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system
11. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
12. The rat brain synucleins: Family of proteins transiently associated with neuronal membrane
13. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
14. Synuclein proteins and Alzheimer's disease
15. Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions
16. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease
17. Localization of Alzheimer βA4 amyloid at presynaptic terminals
18. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice
19. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor
20. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein
21. Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP)
22. Reduction of neurological damage by a trophic peptide segment of the amyloid β/A4 protein (APP)
23. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury
24. Alzheimer-type neuropathology in transgenic mice overexpressing V717F (-amyloid precursor protein
25. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease
26. Age-dependent neuronal and synaptic degradation in mice transgenic for the C terminus of the amyloid procursor protein
27. Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle
28. Apolipoprotein E, synaptic plasticity and Alzheimer's disease
29. The structure of the presenilin 1(S182) gene and identification of six novel mutations in early onset AD families
30. Immunohistochemical analysis of presenilin-1 expression in the mouse brain
31. Presenilin 1 is required for Notch 1 and D111 expression in the paraxial mesoderm
32. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease
33. Synaptic degeneration is the primary neuropathological feature in prion disease: A preliminary study
34. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system
35. Prion protein is necessary for normal synaptic function
36. Partial characterization of murine huntingtin and apparent variations in the subcellular localization of huntingtin in human, mouse and rat brain
37. Cellular localization of the Huntington's disease protein and discrimination of the normal, and mutated form
38. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue